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Abstract
Background: Since 2006, cases of haemorrhagic diathesis in young calves have been observed with a much
higher incidence than previously known. The syndrome, now uniformly called Bovine Neonatal Pancytopenia (BNP),
is characterized by multiple (external and internal) haemorrhages, thrombocytopenia, leukocytopenia, and bone
marrow depletion. Although various infectious and toxicological causes of bleeding disorders in calves have been
ruled out, the aetiology of BNP remains unknown. However, field observations have led to the hypothesis that the
aetiological principle may be transmitted to calves via colostrum.
The objective of the present study was to verify whether ingestion of colostrum from dams of known BNP calves
can elicit signs of BNP and typical haematological findings in conveniently selected neonatal calves. Six such calves
received one feeding of colostrum (or a mixture of colostrum batches) from dams of known BNP calves. As
controls, another six conveniently selected calves from herds which had never had a BNP case received one
feeding of colostrum from their own dams. Haematological and clinical parameters were monitored.
Results: One of the six experimental calves never showed any haematological, clinical or pathological evidence of
BNP. In the other five calves, thrombocyte and leukocyte counts dropped within a few hours following ingestion
of colostrum. Of those, three calves developed clinical signs of BNP, their post-mortem examination revealed bone
marrow depletion. Of the remaining two calves, a pair of mixed twins, marked thrombocytopenia and recurrent
leukocytopenia was evident in one, in which only slight changes in the bone marrow were detected, while in the
other thrombocyte counts dropped, but rebounded later, and no bone marrow changes were noted. Thrombocyte
counts of the experimental calves were statistically significantly lower than those of the control calves at 2 hours
post ingestion of colostrum and at every sampling point between 9 hours and 8 days postcolostral. Leucocyte
counts of the experimental calves were statistically significantly lower than those of control calves at 2 hours post
ingestion of colostrum and 3-7 days postcolostral.
Conclusions: BNP can be induced in some calves by ingestion of colostrum from cows that have given birth to
BNP calves.
Background
During the 20 years preceding 2006, sporadic cases of
unexplained bleeding in cattle of various ages, including,
in 1989 and 1991, two calves less than four weeks of age
with panmyelophthisis, were admitted to our clinic. Start-
ing in 2006, there has been a remarkable surge in cases of
bleeding disorder in young calves. In December, 2009, the
scientific name “Bovine Neonatal Pancytopenia” (BNP)
was adopted for this syndrome because of the characteris-
tic changes in haematological parameters. Other names
are “haemorrhagic diathesis”, “bleeding calf syndrome” or
“blood sweating”. The disease is defined by multiple
(external and internal) haemorrhages, thrombocytopenia,
leukocytopenia, and bone marrow depletion in calves
younger than four weeks [1-9]. No consensus exists with
regard to presence of BVDV as an exclusion criterion.
While the increase in incidence was first noted in
Bavaria, cases have also been recorded in other federal
states of Germany, albeit with striking differences in inci-
dence. Other European countries (e.g. United Kingdom,
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Ireland, Netherlands, Belgium, Luxembourg, France, Italy,
Spain) have also reported cases [10,11]. Various known
causes of bleeding disorders (e.g. genetic, such as the her-
editary platelet disorder in Simmental cattle, toxic causes
such as intoxication by bracken fern, infectious causes due
to e.g. parvo-virus) have been ruled out [1-3,12-14], but
the cause is still unknown. Kappe et al. [14] reported the
detection of PCV2-antigen in five of 25 calves with BNP
and in one of eight control calves and discussed an aetio-
logical role of this virus, while in the investigations of
Mueller et al. [3] and Willoughby et al. [12] PCR testing
for PCV2 gave negative results. No cases were reported
from countries free of BVD or without vaccination against
BVD, e.g. Denmark, Austria, and Switzerland.
The age at first appearance of clinical signs (mean
14 days) and observations by farmers were compatible
with an aetiological role of colostrum. Except for one
unconfirmed report from Scotland [15] we are not
aware of any evidence of thrombocytopenia occurring
before colostrum intake.
The objective of this study, therefore, was to investi-
gate the effect of colostrum of cows that had given birth
to at least one calf affected by BNP on neonatal calves
from farms where the disease had never occurred. The
trial was approved by the ethics committee of the gov-
ernment of Upper Bavaria, and was carried out in coop-
eration with the Bavarian Authority of Health and Food
Safety.
Methods
Hypotheses and sample size determination
The sample size determination was based on following
assumptions and hypotheses:
• The incidence of BNP among the cattle population
(an estimated 50 cases among 1 million calves per
year would yield a probability of 0.00005 for the
chance occurrence of the disease in a randomly
selected calf - these numbers originated from the
incidence observed in Bavaria at the time of the
sample size determination). Therefore the null
hypothesis was that the disease could not be repro-
duced by the feeding of colostrum, but that the dis-
ease occurs with a sporadic incidence of 0.00005.
• At the time of the sample size determination, own-
ers of farms with BNP reported that more than half
of the cows that had given birth to a calf later
affected by BNP had another affected calf in the sub-
sequent year. Therefore the alternative hypothesis
stated that the disease can be provoked in at least
50% of the cases by feeding colostrum of cows that
had already had an affected calf to neonatal calves of
“unsuspicious” dams.
• For the sample size determination a power of 90%
was chosen in a one-sided test for one proportion,
and four animals were calculated as minimal sample
size. Two additional animals were enrolled as
reserves in case of unexpected losses.
• Since no information on thrombocyte counts in
calves during their first few hours of life were found
in the literature, six healthy calves were sampled as
controls.
Dams
The dams of the experimental calves (three Holstein
Friesians and two Brown Swiss) stood in one of two
large dairy farms where BNP had never occurred. The
dams of the control calves were six healthy cows (five
Holstein Friesians and one Simmental) that had been
purchased by the clinic for a different study from farms
where BNP also had never occurred. Dams of all calves
used in the experiment (experimental and control
calves) were tested for BVDV-antigen (BVDV-Ag
ELISA: Idexx) and BVD antibodies (ELISA: Svanovir
BVDV Antibody®). Tests were performed according to
the manufacturers’ recommendations. According to
their history, as reported by the herd owners and local
veterinarians, none had been vaccinated against BVD
but all had been vaccinated against Bluetongue in the
course of a mandatory vaccination campaign during
2008 and 2009 (Bluevac-8®: Boehringer/CZV Veteri-
naria). The dams of all experimental calves and all con-
trol calves, except for calf 8, had detectable BVDV
antibodies. BVDV antigen was not detected in any of
the samples.
The four dams whose colostrum was used for the
experimental calves originated from two farms with
multiple cases of BNP since 2006. All four dams had
been vaccinated with a particular inactivated BVD vac-
cine (PregSure-BVD®: Pfizer). Both farms started their
BVD-vaccination programme for preventive reasons
(farm a started in 2005 with PregSure-BVD®: Pfizer,
farm b started in 2000 with Rispoval®: Pfizer and
switched to PregSure-BVD®: Pfizer in early 2006). In
both herds, no evidence of the presence of PI animals
had been found on the basis of young stock serology.
Therefore, examination for BVDV antigen and BVDV
antibodies was intentionally omitted. During 2008 and
2009, these cows were also vaccinated against Blueton-
gue (Bluevac-8®: Boehringer/CZV Veterinaria). Informa-
tion on these four dams is given in Table 1. Two of the
cows (A and B), originating from one farm (a) had
already had two calves with BNP each (in 2008 and
2009). The other two cows (C and D) originated from
the second farm (b). One (C) had had a case among her
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offspring in 2008 and her colostrum from 2009 was not
used on the farm. The calf born in 2009 of the other
dam (D) was a confirmed case of BNP. All colostrum
batches originated from the year 2009.
Experimental calves
Six calves born within a 30 hour interval (July 2009)
were purchased from two large dairy farms (I and II)
where BNP has never occurred previously (and has not
occurred since). The calves (see Table 1) were delivered
by three (9, 6, and 4 year-old) Holstein Friesian (HF)
and two (10 and 3 year-old) Brown Swiss cows. Calves 5
and 6 were mixed twins born by an HF cow. All calves
were transported together to a barn close to the clinic
one day after birth (calves 1 and 2) or on the day of
birth (calves 3 - 6). There, the calves were housed in
individual boxes with slatted wooden floors and straw
bedding. The barn had not been used for housing cattle
for several years.
Control calves
Six calves (three HF, one Simmental, one HF × Belgian
Blue, and one HF × Simmental cross calves) that were
delivered by natural parturition in the clinic, except for
calf 8, which was delivered by Caesarean section in the
clinic, were enrolled as control calves. The calves were
kept in the same way as the experimental calves, but in
the clinic.
Feeding of calves
All calvings occurred under supervision so that the
calves could not drink colostrum directly from their
dams. Colostrum was provided to all calves in nipple
buckets.
The experimental calves were fed one meal of colos-
trum from cows that had had at least one affected BNP
calf in the past. Batches of colostrum had been stored at
-20°C and shortly before the colostrum was offered to
the calves it was thawed and warmed in a water bath.
Since not all colostrum samples exceeded three litres,
some calves received a mixture of colostrum batches
from two different cows. The matching of experimental
calves and colostrum batches is listed in Table 1. The
first colostrum intake was between 1.5 and 4.5 hours
after birth and all calves, except the twins (no. 5 and 6)
received the colostrum on their farm of origin. The
twins were fed their first meal at the barn close to the
clinic. Calves 1 - 4 received three litres of colostrum,
and the twins (calves 5 and 6) received two litres of
colostrum.
The control calves received three litres colostrum each
from their own dams, which was milked at the clinic
and offered to the calves within 1 to 3 hours after birth
(Table 1).
Following the first meal of colostrum, all calves were
fed whole milk three times a day at a daily volume of
approximately 12% of body mass. The milk originated
from healthy cows milked at the clinic and at a neigh-
bouring farm and was pasteurised at the clinic before
feeding. An exception was the second and third meal
for calves 1 and 2 of the experimental group that
received whole tank milk from their farm of origin.
Fresh water, hay, and calf starter were offered free
choice daily.
Table 1 Information on experimental and control calves and the batches of colostrum fed
Calf (no.) Breed Calf
from
farm






1 Holstein Friesian (HF) I 50% A (2nd milking)+ 50% B (1st milking) a 3
2 Crossbreed* I 50% A (2nd milking)+ 50% B (1st milking) a 3
3 HF II A (1st milking) a 3
4 Crossbreed* I C (1st milking) b 3
5 HF (twin of calf 6) I 25% C (1st milking)+ 75% D (1st milking) b 2
6 HF (twin of calf 5) I 25% C (1st milking)+ 75% D (1st milking) b 2
Control calves
7 Crossbreed** III From its own dam 3
8 Simmental IV From its own dam 3
9 Crossbreed** V From its own dam 3
10 HF VI From its own dam 3
11 HF VII From its own dam 3
12 HF VII From its own dam 3
* Brown Swiss × Belgian Blue; ** HF × Simmental; *** HF × Belgian Blue.
All colostrum batches used were from 2009Cows from which the colostrum was used: A and B had calves with BNP in 2008 and 2009;
C had a calf with BNP in 2008; the colostrum of 2009 was not used on the farm, only in the experiment; D had a calf with BNP in 2009.
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Blood sampling (all calves)
An intravenous cannula was placed in a jugular vein of
the experimental calves, and precolostral blood samples
were taken. The cannula was left in place as long as
possible, which varied between 3 and 14 days. If it had
to be removed, calves were sampled by venipuncture.
While the cannula was left in place, the cannula was
flushed prior and post blood sampling with sodium-
citrate solution, and the first 10 ml of blood sampled
were discarded. If no cannula was left, an 18-gauge
(1.2 × 40 mm) needle was used to harvest blood directly
into an EDTA-sample tube; no Vacutainer® was used.
The intervals between sampling and testing varied
between 15 minutes and 24 hours (due to the fact that
some samples were taken on the farm of origin).
The control calves were bled by venipuncture at
exactly the same time points as the experimental calves.
The intervals between sampling and testing also varied
between 10 minutes and 20 hours (due to the fact that
some control calves were born during the weekend).
The times of blood sampling and the analyses per-
formed for all calves (experimental and controls) are
listed in Table 2. In addition to haematological and bio-
chemical examinations these samples were tested for
pestiviral genome by duplex real-time RT-qPCR [16]
and the presence of BVDV antibodies by ELISA (Svano-
vir BVDV Antibody®) (Table 2).
Determination of cell numbers was performed using
the semi-automated haematology analyser Sysmex F-820.
Clinical examination and termination of trial (all calves)
The study was approved by the ethics committee of the
government of Upper Bavaria (ref-nr. 55.2-1-54-2531-
56-09).
The calves were planned to be observed for four
weeks. Each day the calves were examined clinically
with special attention being paid to the skin, oral
mucosa, and faeces. Body temperature was measured
daily. Calves were treated with antibiotics and/or an
NSAID as indicated on the basis of clinical findings.
Euthanasia was carried out when obvious BNP or other
severe diseases (e.g. septic arthritis or purulent
omphalophlebitis) developed which did not respond to
conservative treatment within three days or if the calves
did not drink their meals three times in a row. It was
necessary to allow development of the full range of clin-
ical signs, including haemorrhages, in order to demon-
strate the role of colostrum in this disease and allow for
refinement in future studies.
All calves were sent for post-mortem examination
immediately after euthanasia to the Bavarian Authority
of Health and Food Safety (Oberschleissheim). Bone
marrow of the femur and sternum was used for histolo-
gical examination.
The control calves were not euthanized due to ethical
and economical considerations, but were sold after
being observed for four weeks.
Statistical analysis
Data on thrombocyte and leukocyte counts were analysed
in MS Excel (Version 2007) and SPSS (version 18, http://
www.spss.com). Due to the fact that statistical analysis was
performed with six animals only per group, non-para-
metric tests were chosen. For comparison of blood values
between the two groups Mann-Whitney-U tests were
employed. A significance level of p < 0.05 was used. For
graphical display the medians and quartiles were used.
Results
Laboratory data
In five of the six experimental calves the thrombocyte
and leukocyte values dropped within the first three
hours after intake of colostrum. Afterwards the courses
varied.
For comparison, the courses of thrombocyte and leu-
kocyte counts as well as haematocrit in the experimental
and control calves for the first 10 days of the trial are
shown in Figures 1, 2, 3.
Figure 4 shows the courses of thrombocyte counts in
all six experimental calves.
The thrombocyte and leukocyte counts of the control
calves were never below the respective reference ranges
(Figures 1 and 2). The haematocrit in the six experimen-
tal calves and six control calves (Figure 3) declined over







Precolostral X X X X
1,2,3,4,6,9,12 h pc* X
24 h pc X X
48 h pc X X X
Daily until day 14** X
After day 14 every 2nd to 3rd day until euthanasia or day 28 X
*pc = postcolostral ** with few exceptions due to laboratory shifts.
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Figure 1 Medians of thrombocyte counts of experimental and control calves in the study. Medians of thrombocyte counts of six
experimental calves following one feeding of colostrum from specific cows and six control calves fed with colostrum from their own dams. The
shaded area represents the reference range; first and third quartile are displayed by error bars, time points with statistically significant differences
between the values of experimental and control calves are indicated by *.
Figure 2 Medians of leukocyte counts of experimental and control calves in the study. Medians of leukocyte counts of six experimental
calves following one feeding of colostrum from specific cows, and six control calves fed with colostrum from their own dams. The shaded area
represents the reference range; first and third quartile are displayed by error bars, time points with statistically significant differences between
the values of experimental and control calves are indicated by *.
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Figure 3 Medians of haematocrit of experimental and control calves in the study. Medians of haematocrit of six experimental calves
following one feeding of colostrum from specific cows, and six control calves fed with colostrum from their own dams. The shaded area
represents the reference range; first and third quartile are displayed by error bars.
Figure 4 Individual thrombocyte counts of six experimental calves in the study. Individual thrombocyte counts of six experimental calves
following one feeding of colostrum from specific cows, shown for the whole duration of the study. The shaded area represents the reference
range.
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time, but there was no statistically significant difference
at any time between the two groups. The comparison of
blood values between experimental and control calves
revealed statistically significant (p < 0.05) differences in
thrombocyte counts at two hours and at every sampling
time from 9 hours up to day 8 and day 10 after colos-
trum intake, and in leukocyte counts two hours, and
every day from day two to day seven after colostrum
intake.
Globulin values of the experimental and control calves
are presented in Table 3. In all calves a rise in globulin
concentration occurred within 24 or 48 h of colostrum
ingestion. At no time point statistical significant differ-
ences existed between experimental and control calves.
No pestiviral genome or BVDV antibodies were
detected in the precolostral blood samples of the experi-
mental and control calves; but BVDV antibodies were
present in postcolostral serum samples from all experi-
mental calves and five of the six control calves. All
dams of the experimental calves yielded negative results
in the RT-qPCR for the presence of pestiviral genome,
but had antibodies against BVDV in the serum. The
dams of the control calves also yielded negative results
in the examinations for panpestiviral genome and in five
of the six cows, BVDV antibodies were detected in the
serum.
Clinical findings
All experimental calves were treated with antibiotics
(cefquinome or tulathromycine) and an NSAID (meloxi-
cam) as indicated on the basis of clinical findings.
Only pertinent findings are reported.
Calf 1 had small amounts of blood in the faeces inter-
mittently on 9 days (day 4, 6, 8, 12, 13, 15, 16, 19, 22),
but did not show any other signs of a bleeding disorder
(such as petechiae or external haemorrhages). It had
short episodes of diarrhoea on days 2 to 4, and on
day 14. On these days the behaviour of the calf was dull.
The body temperature was never higher than 40°C but
between 39.5 and 40.0°C on 8 days (6, 9, 10, 12-14,
16, 19). The intravenous cannula was removed on day 8,
but thrombophlebitis developed nevertheless. This calf
was euthanized on day 23 because of severe unilateral
gonitis with obvious lameness.
Calf 2 had diarrhoea on day 3. On this day and the
day before, the behaviour of the calf was dull. On day 4
the faeces contained a small amount of blood as judged
by visual inspection and the amount increased daily.
Starting on day 6, petechiae could be seen. The body
temperature was higher than 39.5°C only on day 8
(39.6°C). The intravenous cannula was fully functional
until euthanasia without development of thrombophlebi-
tis. The calf was euthanized on day 9 because of clinical
signs consistent with the development of BNP.
The behaviour of Calf 3 was dull on days 2 and 9.
A moderate navel infection began on day 4. On days 3, 5,
and 6 the faeces had small amounts of blood as judged by
visual inspection; the amounts increased from day 8
onward. Starting on day 9, petechiae could be seen and
they increased in intensity each following day, and start-
ing on day 10, the calf showed prolonged bleeding. The
body temperature was higher than 39.5°C only on day 7
(39.7°C). The intravenous cannula was removed on day 4;
the calf developed a moderate thrombophlebitis. It had
to be euthanized on day 12 because of clinical signs con-
sistent with the development of BNP.
Calf 4 had diarrhoea on day 3. During the first 3 days,
its behaviour was dull. A moderate navel infection began
on day 4. On days 5 and 9, the faeces had a small
amount of blood as judged by visual inspection and the
amount increased daily beginning on day 11. Starting on
day 10, petechiae could be seen. Prolonged bleeding and
haematomas were seen on days 13 and 14. The body
temperature was never higher than 40°C but between
39.5 and 40.0°C on 4 days (9, 11-13). The intravenous
cannula was removed on day 7 because of minimal
alteration of the vein, no thrombophlebitis developed.
The calf was euthanized on day 14 because of clinical
signs consistent with the development of BNP.
Calf 5 had very small amounts of blood in the faeces
as judged by visual inspection on days 4 to 14, 16 and
18, but did not show any signs of a bleeding disorder. It
had short episodes of diarrhoea on days 3 and 18. Its
behaviour was dull on days 1, 9, 10 and 19. The calf
developed omphalitis on day 3, which resulted in
obvious omphalophlebitis on day 20 in spite of
Table 3 Globulin concentrations (g/l) of six experimental
calves fed with colostrum of specific cows and six control
calves fed with colostrum of their own dams






1 15.0 33.0 29.8
2 15.5 28.4 28.3
3 19.5 n.a. 31.8
4 17.3 20.4 24.1
5 20.3 23.6 19.2
6 17.8 24.0 24.2
Control calves
7 19.9 58.7 n.a.
8 19.6 n.a. 35.6
9 12.8 30.7 30.5
10 15.3 37.9 34.5
11 12.3 17.6 16.9
12 16.9 34.3 31.9
n.a. = not assessed.
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antibiotic and antiphlogistic treatment. The body tem-
perature was higher than 40°C on day 16 (40.2°C) and
between 39.5 and 40.0°C on 7 days (8-10, 13-15, 18).
The intravenous cannula was removed on day 5, but a
thrombophlebitis developed nevertheless. This calf was
euthanized on day 22 because of severe unilateral carpi-
tis with obvious lameness.
The behaviour of Calf 6 was dull on the first two
days. An omphalophlebitis began on day 5 and grew
worse from day to day in spite of intensive antibiotic
and antiphlogistic treatment. On day 11 the faeces con-
tained a small amount of blood as judged by visual
inspection. On this day, the amount of blood in the
faeces was increased. On days 6 to 8 and 13, petechiae
could be seen. The body temperature was higher than
40°C on two days (10, 11) and between 39.5 and 40.0°C
on 2 days (12, 13). The intravenous cannula was
removed on day 2. The vein remained intact. On day 13
the calf was euthanized because of omphalophlebitis.
The control calves never showed any clinical signs
(except for brief episodes of diarrhoea).
Gross pathology and histopathology
Calf 1 had few petechiae on the ventral aspect of the
tongue, pulmonary pleura, and on the thymus, but no
overt haemorrhages. Septic gonitis was confirmed. Bone
marrow histology was normal (Figure 5).
Calf 2 had multiple and extensive internal and gastro-
intestinal haemorrhages and haematomas, only few
megakaryocytes were found in the bone marrow of both
femur and sternum, whereas the numbers of other pre-
cursor cells were only moderately reduced (Figure 5).
The gross pathology of calves 3 and 4 was similar to
that of calf 2. In the bone marrow of both femur and
sternum no megakaryocytes and only few precursor
cells were found (Figure 5).
The clinical findings of omphalophlebitis, septic carpi-
tis and thrombophlebitis in calf 5 were confirmed. Few
petechiae were detected on the ventral aspect of the
tongue and in the pharynx. Bone marrow histology was
normal (Figure 5)
The clinical finding of severe omphalophlebitis in calf
6 was confirmed. Small haemorrhages on the thymus,
abomasal serosa, and in the mesenterium were present.
In the bone marrow of both femur and sternum, precur-
sor cells and megakaryocytes were present, albeit in
reduced numbers (Figure 5).
Except for calf 3, various bacteria species were found
in several organs of all calves.
Discussion
Choice of colostrum
As not all batches of colostrum supplied by various farm-
ers had a volume exceeding three litres, a choice had to
be made between feeding a homogenous mixture of dif-
ferent batches and feeding different colostrum batches to
different calves. The obvious advantage of the first option
would have been standardisation of the colostrum offered
to the calves. This approach would have required thawing
and thorough mixture of a number of batches of colos-
trum, followed by re-freezing and re-thawing for use.
This might have damaged the (unknown) aetiological
principle. Another possible disadvantage would have
been the dilution of the aetiological agent below a thresh-
old of effect. Because of this, it was decided to feed differ-
ent batches of colostrum to the individual calves, where
possible. In the case of the twins (calves 5 and 6), there
were two batches of colostrum of three and one litre left.
It was decided to feed them equal volumes; hence these
two batches were mixed. The fact that calves 1 and 2
received a mixture of two colostrum batches was due to
a misunderstanding but in retrospect proved to be very
valuable (see the section on aetiology and pathogenesis).
Laboratory data
In the reviewed literature only very few papers deal with
normal haematology of very young calves, and either
report no precolostral samples nor the exact times post
colostrum [17] or only indicate an interval during which
samples were taken [18-20]. However, none of the arti-
cles report values below the reference ranges used here.
As demonstrated by the values obtained from the con-
trol calves, it is unlikely that the observations reported
in the experimental calves are normal occurrences in
neonatal calves.
Except in calf 1, the courses of thrombocyte counts
show a similar pattern in all experimental calves: there
was an initial drop within a few hours after colostrum
Figure 5 Bone marrow sections of the femur* of experimental
calves and one healthy calf. Bone marrow sections of the femur
of six experimental calves following one feeding of colostrum from
specific cows and one healthy calf.* The picture of calf 1 is taken
from the sternum.
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intake, followed by a temporary rise for a few days, and
a final drop to extremely low levels in calves 2, 3, 4,
and 6. Calf 5 made a remarkable recovery. On the basis
of an average lifespan of thrombocytes of 5 to 9 days
[21], about 10 to 20% of thrombocytes can be expected
to be removed and replaced per day, or roughly 0.5 to
1% per hour. Thus, even sudden and complete cessation
of thrombocyte release from bone marrow could not
explain the drop in peripheral thrombocyte counts
recorded in the experimental calves in this trial. Hence
peripheral destruction must be the main cause.
The drop in thrombocytes cannot be explained by dif-
ferences in handling following blood sampling. Further-
more, the time between sampling and testing did not
affect the number of thrombocytes notably. During a
pre-trial blood was sampled and examined at different
points up to 72 hours post sampling. There was no
notable change in the values obtained. Also the repeat-
ability was evaluated by testing the same blood samples
10 times in a row. There again, no notable differences
were found. Therefore it is concluded that the values
obtained for the thrombocytes and leukocytes in this
study were not influenced by the methods applied. It is
also highly unlikely that this drop was caused by trans-
portation of the calves, as the drop was already seen in
the first hours after ingestion of colostrum, which was
before transportation in calves 1 - 4.
The undulating course in leukocyte counts (Figure 2)
may reflect initial peripheral destruction and transen-
dothelial migration, subsequent recruitment, and final
depletion due to bone marrow damage. The extremely
low levels in affected calves clearly show that both
mononuclear cells and granulocytes are affected. Again,
no such pattern was seen in the leukocyte counts of the
control calves (Figure 2).
Clinical findings
Most of the experimental calves were somewhat sub-
dued during the first few days. It is assumed that this
was due to the transport to the barn on a hot summer
day, and the change in environment.
A remarkable finding was that despite the evidence of
generalised bacterial infections in five of the six calves,
there were only three days on which one of two calves
(calves 5 and 6) had a body temperature above 40°C.
Therefore, fever does not seem to be a consistent char-
acteristic of BNP. This is in contrast to findings
described earlier [1,22].
The first clinical signs in calf 2 were blood in the faeces
(day 4) and petechiae on day 6. Calves 3 and 4 showed
similar clinical courses as calf 2. They had distinct
amounts of blood in the faeces on days 8 and 11, and
petechiae on days 9 and 10, respectively. Compared with
data given in the literature (average age of 16 days [13] or
17 days [14]) the clinical signs of the bleeding disorder in
the experimental calves of this study occurred much ear-
lier. This may be explained by the fact that the calves in
this study were examined daily, with special attention
being paid to any signs of bleeding disorder, whereas the
cases described in the literature may have been detected
at later stages of the disease.
Calves 1 and 5 did not develop unequivocal clinical
signs of BNP, but had small amounts of blood in the
faeces on several days. The postcolostral rise in globulin
levels indicates satisfactory resorption of colostrum in
all calves. Therefore, failure of resorption cannot be the
reason for the differences in the clinical and haematolo-
gical outcomes.
The high incidence of processes associated with local
or systemic bacterial infections in the experimental
calves, requiring intensive treatment, despite isolated
housing needs an explanation. Impairment of both local
and systemic resistance due to the leukopenia observed
seems to be the most plausible reason. Whether calves
exposed to the aetiological agent develop either BNP or
systemic infections cannot be decided on the basis of
available data.
Gross pathology and histopathology
The histological findings in the bone marrow of the six
experimental calves indicate that the disease is not an
all-or-nothing phenomenon; instead, there can be gra-
dual differences. As Figure 5 shows, there are distinct
differences in the bone marrow histology of the six
experimental calves. Bone marrow histology of calves 1
and 5 was judged normal, while the bone marrow of
calves 3 and 4 showed distinct features of BNP, with no
megakaryocytes and only few precursor cells being left.
Findings in calves 2 and 6 were not as clear-cut.
Although the bone marrow of calf 2 was also judged as
being indicative of BNP, the bone marrow of both
femur and sternum was not as severely affected as in
calves 3 and 4; there were few megakaryocytes left, and
other precursor cells were only moderately reduced. Calf
6 showed the least changes, with both megakaryocytes
and precursor cells present, but in reduced numbers.
Therefore, it cannot be excluded that this calf was
affected by BNP, but either at an early stage or in a less
severe form. It is not known if such a less severe form
of the disease exists, but there is anecdotal evidence that
some affected calves do survive the disease.
The control calves were not euthanized due to ethical
and economic considerations, therefore no post-mortem
examinations or bone marrow examinations are avail-
able for these calves. However, their blood values never
showed any indication of disturbed production of blood
cells. Therefore, it is unlikely that these calves would
have shown any bone marrow changes.
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In summary, the clinical, haematological and post mor-
tem findings in three of the six experimental calves clearly
met the defining characteristics of BNP [1-3,5-9,13].
Whether the thrombocytopenia and blood admixture in
the faeces on calf 6 on the day of euthanasia heralded BNP
or were consequences of septicaemia remains open to
speculation. The findings of bone marrow histology in this
calf can be explained by both processes.
Speculations on aetiology
The fact that calves of various breeds have been simulta-
neously affected in Europe [13-15,23], as well as among
the experimental calves of this study all but rules out an
exclusively genetic cause of the syndrome.
Most other possible causes of bone marrow depletion
in young calves have been excluded [1]. In view of the
very short interval between colostrum intake and
changes in blood values, any infectious agent trans-
mitted via colostrum would have to have very unusual
properties. Also, a cell-mediated mechanism seems unli-
kely, as the colostrum batches had been stored at -20°C
for at least two months. This mainly leaves toxins and
antibodies as candidates for aetiologic principles. (Low
molecular) toxins would be expected to cross the pla-
cental barrier during pregnancy. Therefore, haematologi-
cal changes would be expected in precolostral calves. All
references in the literature, except for one [15] describe
no changes in precolostral calves. One possible hypoth-
esis currently being discussed is an immunopathological
reaction due to antibodies - which could be transmitted
via colostrum. Many research groups are working on
identifying these specific antibodies in the colostrum of
cows that have had affected calves. To our knowledge,
no specific antibodies have been identified that are
linked to the disease. However, all cows whose colos-
trum was used had been vaccinated against BVD with
the vaccine PregSure-BVD®, while none of the dams of
the control calves had been vaccinated against BVD.
This vaccine was taken off the market in Germany in
April, 2010, and in all of Europe in June, 2010, by a
voluntary decision of the company. It might be possible
that vaccination with this vaccine induces the produc-
tion of specific antibodies which are transmitted via
colostrum to the calves and get absorbed and than bind
to both peripheral blood cells and stem cells in the bone
marrow of the calves. However, these are speculations,
and no evidence has yet been published in the literature.
As no precipitous drops in the erythrocyte counts nor
signs of haemolysis were recorded, peripheral destruc-
tion of erythrocytes does not seem to be a component
of the syndrome. The long lifespan of erythrocytes (100
days) [24] explains the relatively slow decline in haema-
tocrit despite bone marrow depletion of all precursor
cell lines.
According to the history given by the owners of the
dams of the experimental calves and the owners of the
dams of the control calves, none of the cows had been
vaccinated against BVD; yet all the former and five out
of six of the latter group had antibodies against BVD,
indicating previous natural infection. In view of the high
prevalence of BVD-seropositive animals among the cat-
tle population, this is not surprising, and offers no
explanation for the development of BNP in experimental
calves.
The aetiological role of colostrum seems to be con-
firmed by the results of this study. The data presented
in Table 1 indicate that all batches of colostrum used
had the potential to cause BNP. The colostrum donor
cows were selected specifically because they had already
had at least one calf affected by BNP. This may explain
the high proportion of calves that reacted to the inges-
tion of colostrum seen in this study. Even with under-
detection and under-reporting of cases, the incidence of
BNP in the field is relatively low. Therefore, it must be
assumed that only few cows have the aetiological princi-
ple in their colostrum. Some individual predisposition
can also be speculated to be present in the calves. This
is evidenced by calves 1 and 2: each received three litres
of the same mixture of colostrum batches from two
cows. Since the calves were born within about half an
hour of each other, the intervals between birth and
ingestion of colostrum were comparable. Also, postco-
lostral globulin concentrations in serum were similar
(Table 3). Thrombocyte counts in calf 2 dropped below
the reference range within two hours after colostrum
intake and subsequently never increased. This calf was
the first one to develop signs of BNP and had to
be euthanized on day 9. By contrast, calf 1 showed
neither a drop in thrombocyte counts nor unequivocal
signs suggestive of BNP. Therefore, it seems that the
specific colostrum is not pathogenic for all calves, but
possibly only to calves with an appropriate individual
predisposition.
Some results of calves 5 and 6 also suggest that BNP
may not be an all-or-nothing phenomenon. Further-
more, personal observation of patients in our clinic
shows that some calves recover from overt disease, and
some calves are affected subclinically, showing reduced
blood values of thrombocytes and leucocytes, but no
clinical signs of BNP (like calf 5). Whether the severe
infectious processes that are a plausible explanation for
the episodes of moderate fever, and necessitated eutha-
nasia in calves 1, 5 and 6 were due to the lack of
immune cells remains unclear. An alternative explana-
tion for the fever would be massive cell destruction. The
fact that the calves did not receive colostrum from their
own dams may also have contributed to this course of
events.
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Since the haematological changes occurred well before
any treatments were administered, any influence of
treatments on the course of events seems very unlikely.
Conclusions
The results of this study demonstrate that BNP can be
reproduced in some neonatal calves by ingestion of
colostrum from individual cows that are somehow pre-
disposed to the disease. The available evidence is best
explained by the presence in colostrum of a non-
cellular, non-infectious agent that leads to a dramatic
decline in peripheral blood cell counts (thrombocytes
and leukocytes) and all precursor cell lines in bone mar-
row until complete cell depletion.
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